Medication info

Empagliflozin 10 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›10mg / 1 tablet
Manufacturer / importer
Myeongmun Pharmaceutical Co., Ltd.
Appearance
Light yellow, biconvex, round film-coated tablets
Packaging
10 tablets/box [10 tablets/PTPX1], 30 tablets/box [10 tablets/PTPX3], 30 tablets/bottle
Approval status
Active

MFDS item code 202102094 · Approved 2021.03.05

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes
Who takes it
Adults
Adult dose
The recommended dose of this drug is 10 mg once daily for monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this drug is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this drug is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions, 3. Adverse Reactions). This drug may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose on the same day. Special populations • Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Treatment with this drug should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this drug well but have a persistent eGFR < 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. This drug should be discontinued if the eGFR decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this drug in patients with end-stage renal disease (ESRD) or who are on dialysis, as efficacy is not expected. • Patients with hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this drug is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. • Older adults No dose adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years and older. Initiation of this drug is not recommended in adults aged 85 years and older because clinical experience is limited (see Precautions, 4. General Precautions).

Ingredients

Manufacturer
Myeongmun Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes

  • Type 2 diabetes
  • difficulty in blood sugar control
View approved original text

This medication helps control blood sugar in adults with type 2 diabetes in conjunction with diet and exercise. It can be administered alone or in combination with metformin if previous diabetes medication treatment has not occurred or if blood sugar control is difficult with monotherapy. Furthermore, it is used in combination with this medication when sufficient blood sugar control is not achieved while using either metformin monotherapy or metformin in combination with other diabetes medications (such as pioglitazone or sulfonylureas). This medication may also be added for patients using insulin therapy if necessary. For type 2 diabetes patients with cardiovascular diseases, it is important to refer to expert information regarding its impact on cardiovascular events. In summary, this medication is used to enhance blood sugar control in patients with type 2 diabetes.

How to take

Adult dose

The recommended dose of this drug is 10 mg once daily for monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this drug is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this drug is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions, 3. Adverse Reactions). This drug may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose on the same day. Special populations • Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Treatment with this drug should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this drug well but have a persistent eGFR < 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. This drug should be discontinued if the eGFR decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this drug in patients with end-stage renal disease (ESRD) or who are on dialysis, as efficacy is not expected. • Patients with hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this drug is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. • Older adults No dose adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years and older. Initiation of this drug is not recommended in adults aged 85 years and older because clinical experience is limited (see Precautions, 4. General Precautions).

Precautions

This medication should not be administered to certain patients. Firstly, patients with allergic reactions to the ingredients of this medication should not take it. Secondly, this medication is not suitable for patients with type 1 diabetes or diabetic ketoacidosis. Thirdly, patients with severely impaired kidney function, that is, with a glomerular filtration rate of less than 30 mL/min/1.73m2, or those with end-stage kidney disease or on dialysis should avoid using it. Fourthly, since this medication contains lactose, it should not be administered to patients with genetic metabolic abnormalities such as lactose intolerance or galactose intolerance. In patients with mild impairment of kidney function, it should be administered with caution. For patients with a glomerular filtration rate of less than 60 mL/min/1.73m2, dosage adjustment or discontinuation might be required. This medication is not used for patients with end-stage renal disease or those on dialysis due to lack of expected effectiveness. Additionally, it is important to monitor kidney function regularly. In patients with congestive heart failure of NYHA class I-II, caution is required while use is not recommended for those in NYHA class III-IV. If this medication is taken in conjunction with insulin or insulin secretagogues such as sulfonylureas, there may be a risk of hypoglycemia, hence dosage adjustments may be necessary. During the course of treatment, there may be side effects such as hypoglycemia, infections, increased urination, urinary tract infections, and reduced fluid volume; therefore, vigilance is necessary. Particularly in women, genital infections may occur more frequently, so symptoms should be closely monitored. Ketoacidosis, a serious metabolic abnormality, may occur rarely. If symptoms such as vomiting, abdominal pain, difficulty in breathing, or malaise arise, immediate consultation with healthcare professionals is necessary. In elderly patients, especially those over 75 years, the risk of fluid loss should be carefully monitored regarding blood pressure and fluid status. This medication has been reported to cause serious side effects including dehydration, hypotension, urosepsis, pyelonephritis, and perineal necrosis; immediate treatment is necessary if any abnormal symptoms occur. Use of this medication during pregnancy is not recommended; it should be discontinued upon confirmation of pregnancy. During breastfeeding, this medication may be excreted in breast milk, hence it is advisable to stop breastfeeding. Children under 18 years should not use this medication as safety and efficacy have not been established. No specific toxic symptoms have been reported in cases of overdose; however, appropriate treatment might be necessary depending on a clinical situation. This medication should be stored out of the reach of children and should not be transferred to other containers. During treatment, blood glucose levels and kidney function should be checked regularly, and if symptoms of hypoglycemia or infection occur, immediate consultation with healthcare professionals is necessary. Caution is required when driving or operating machinery, especially if taken with insulin or sulfonylureas due to the risk of hypoglycemia.

Side effects

  • Hypoglycemia
  • Ketoacidosis
  • Vulvovaginitis
  • Balanitis
  • Other genital infections
  • Urinary tract infection
  • Perineal necrosis
  • Itching
  • Rash
  • Urticaria
Show 219 more
  • Angioedema
  • Decreased fluid volume
  • Increased urination
  • Urinary difficulty
  • Interstitial nephritis
  • Thirst
  • Increased serum lipids
  • Increased serum creatinine
  • Decreased glomerular filtration rate
  • Increased hematocrit
  • Ureteral stones
  • Acute kidney injury
  • Cervicitis
  • Hyperglycemia
  • Hyponatremia
  • Diabetic foot
  • Lumbago
  • Glaucoma
  • Pathological myopia
  • Retinal detachment
  • Retinal vein occlusion
  • Retinal detachment with tears
  • Limb injury
  • Road traffic accidents
  • Splenic injury
  • Sternum fracture
  • Angina
  • Prinzmetal angina
  • Coronary artery disease
  • Deep vein thrombosis
  • Acute cholecystitis
  • Autoimmune hepatitis
  • Cholelithiasis
  • Headache
  • Cerebral infarction
  • Intracranial aneurysm
  • Fever
  • Vascular stent stenosis
  • Vascular stent thrombosis
  • Diarrhea
  • Nausea
  • Gastric ulcer
  • Colitis
  • Vomiting
  • Ischemic colitis
  • Colonic bleeding
  • Soft tissue infection
  • Appendiceal abscess
  • Appendicitis
  • Meningitis
  • Chronic otitis media
  • Peritonsillar abscess
  • Pneumonia
  • Pulmonary tuberculosis
  • Acute pyelonephritis
  • Sepsis
  • Subcutaneous abscess
  • Tubal-ovarian abscess
  • Vestibular neuritis
  • Upper abdominal pain
  • Cavities
  • Gastric ulcer
  • Erosive gastritis
  • Abdominal discomfort
  • Dry mouth
  • Gastroesophageal reflux disease
  • Abdominal distension
  • Anal bleeding
  • Chronic gastritis
  • Ischemic colitis
  • Enteritis
  • Bloating
  • Gastric polyps
  • Gingival swelling
  • Passage of bloody stools
  • Hemorrhoids
  • Colonic bleeding
  • Pancreatic cyst
  • Rectal pain
  • Toothache
  • Dyspepsia
  • Gastritis
  • Upper respiratory tract infection
  • Bronchitis
  • Chronic sinusitis
  • Gastroenteritis
  • Helicobacter infection
  • Periodontitis
  • Chronic tonsillitis
  • Conjunctivitis
  • Influenza
  • Laryngitis
  • Paronychia
  • Tinea corporis
  • Dental abscess
  • Nasopharyngitis
  • Shingles
  • Positional vertigo
  • Sensory loss
  • Perceptual disturbances
  • Amnesia
  • Carotid stenosis
  • Diabetic neuropathy
  • Facial paralysis
  • Memory disturbances
  • Neuralgia
  • Parkinsonism
  • Polyneuropathy
  • Sensory disorders
  • Drowsiness
  • CNS-origin dizziness
  • Fatigue
  • Peripheral edema
  • Facial swelling
  • Peripheral swelling
  • Chills
  • Strange sensations
  • Edema
  • Pain
  • Pain at the site of puncture
  • Weight gain
  • ECG abnormalities
  • Decreased hemoglobin
  • Increased hemoglobin
  • Positive Helicobacter test
  • Positive urine red blood cells
  • Hematuria
  • Overactive bladder
  • Renal mass
  • Urinary retention
  • Urological pain
  • Abnormal urine
  • Benign prostatic hyperplasia
  • Erectile dysfunction
  • Atrophic vaginitis
  • Cervical dysplasia
  • Scrotal pain
  • Sexual dysfunction
  • Vaginal discharge
  • Hypoglycemia
  • Decreased appetite
  • Obesity
  • Hyperphagia
  • Hyperlipidemia
  • Vitamin D deficiency
  • Dermoid cyst
  • Seborrheic dermatitis
  • Atopic dermatitis
  • Nummular eczema
  • Heat rash
  • Sebaceous gland hyperplasia
  • Lumbar spinal canal stenosis
  • Myalgia
  • Limb pain
  • Musculoskeletal chest pain
  • Arthralgia
  • Cervical stenosis
  • Fibromyalgia
  • Flank pain
  • Fracture pain
  • Muscle weakness
  • Musculoskeletal pain
  • Osteoarthritis
  • Osteoporosis
  • Rotator cuff syndrome
  • Astigmatism
  • Cataract
  • Allergic conjunctivitis
  • Blurred vision
  • Corneal erosion
  • Ocular discomfort
  • Ocular congestion
  • Eyelid swelling
  • Visual impairment
  • Vitreous floaters
  • Vitreous hemorrhage
  • Epistaxis
  • Asthma
  • Exertional dyspnea
  • Wet cough
  • Allergic rhinitis
  • Residual phlegm
  • Cough
  • Epistaxis
  • Skin lacerations
  • Contusions
  • Rib fractures
  • Concussion
  • Corneal abrasion
  • Falls
  • Hand fractures
  • Iliotibial band syndrome
  • Open globe injury
  • Pelvic fractures
  • Palpitations
  • Tachycardia
  • Atherosclerosis
  • Diabetic vascular complications
  • Peripheral arterial occlusive disease
  • Anxiety
  • Depression
  • Sleep disorders
  • Otalgia
  • Positional vertigo
  • Anemia
  • Lymphadenopathy
  • Hypothyroidism
  • Thyroid nodules
  • Constipation
  • Vulvar pruritus
  • Genital pruritus
  • Dyslipidemia
  • Diabetes
  • Diabetic retinopathy
  • Dry eyes
  • Dyspnea
  • Unstable angina
  • Hypertension
  • Insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air or humidity. Also, it is important to store it at a temperature between 1 to 30 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

Light yellow, biconvex, round film-coated tablets

Package unit

10 tablets/box [10 tablets/PTPX1], 30 tablets/box [10 tablets/PTPX3], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.